Skip to content

Intestinal colonisation with carbapenemase producing enterobacteriaceae after foreign travel

Intestinal colonisation with carbapenemase producing enterobacteriaceae after foreign travel - Traveling bacteria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35813
Enrollment
500
Registered
2011-03-28
Start date
2011-04-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intestinal bacteria New Delhi metallo-beta-lactamase

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All travellers planning a trip outside Europe are invited to participate in the study, aged 18 years and older.

Exclusion criteria

Exclusion criteria: Duration of travel longer than 3 months Travelers carrying an ESBL-producing isolate before travel Companion travellers are excluded in the study

Design outcomes

Primary

MeasureTime frame
Cumulative incidences will be calculate by dividing the number of travellers diagnosted with a positive resistent Enterobacteriaceae by the number of travellers at risk per continent. The incidence rate of positive resistent Enterobacteriaceae will be calculate by dividing the number of travellers with a positive resistent Enterobacteriaceae by the total travel duration in person days. To determine risk factors for contracting a positive resistent Enterobacteriaceae, a logistic regression model will be used.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)